Williams Laboratory

Selected Publications


Lu D, Li J, Liu H, Foxa GE, Weaver K, Li J, Williams BO, Yang T. 2018. LRP1 suppresses bone resorption in mice by inhibiting the RANKL-stimulated NFκB and p38 pathways during osteoclastogenesis. J Bone Miner Res.

Maupin K, Weaver K, Bergsma A, Christie C, Zhong Z, Yang T, Williams BO. 2018. Enhanced cortical bone expansion in Lgals3-deficient mice during agingBone Res 6(7).

Li J, Lu D, Dou H, Liu H, Weaver K, Wang W, Li JD, Yeh E, Williams BO, Zheng L, Yang T. 2018. Demsumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway. Nat Commun 9(1):143.


Valkenburg KC, DeMarzo AM, Williams BO. 2017. Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression. Oncotarget 8(46):80265–80277.

DeBruine ZJ, Ke J, Harikumar KG, Gu X, Borowsky P, Williams BO, Miller LJ, Xu HE, Melcher K. 2017. Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerization. Genes Dev 31(9):916–926.

Li J, Lu D, Liu H, Williams BO, Overbeek PA, Lee B, Zheng L, Yang T. 2017. Sclt1 deficiency causes cystic kidney by activating ERK and STAT3 signaling. Hum Mol Genet 26(15):2949–2960.

Janda CY, Dang LT, You C, Chang J, de Lau W, Zhong ZA, Yan KS, Marecic O, Siepe D, Li X, Moody JD, Williams BO, Clevers H, Kuo CJ, Piehler J, Baker D, Garcia KC. 2017. Surrogate Wnt ligands that phenocopy canonical Wnt/B-catenin signaling. Nature 545(7653):234–237.

Walls GV, Stevenson M, Lines KE, Newey PJ, Reed AAC, Bowl MR, Jeyabalan J, Harding B, Bradley KJ, Manek S, Chen J, Wang P, Williams BO, Teh BT, Thakker RV. 2017. Mice deleted for Cell division cycle 73 (Cdc73) gene develop parathyroid and uterine tumors: model for the hyperparathyroidism-jaw tumour syndrome. Oncogene.36(28):4025–4036.

Droscha CJ, Diegel CR, Ethen NJ, Burgers TA, McDonald MJ, Maupin KA, Naidu AS, Wang PF, Teh BT, Williams BO. 2017. Osteoblast-specific deletion of Hrpt2/Cdc73 results in high bone mass and increased bone turnover. Bone 98:68–78.

Pridgeon MG, Grohar PJ, Steensma MR, Williams BO. 2017. Wnt signaling in Ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. Curr Osteoporos Rep 15(4):239–246.

Yang T, Williams BO. Low-density lipoprotein receptor-related proteins in skeletal development and disease. Physiol Rev 97(3):1211–1228.

Williams BO. 2017. LRP5: From bedside to bench to bone. Bone 102:26–30.

Williams BO, Warman ML. 2017. CRISPR/Cas9 technologies. J Bone Miner Res 32(5):883–888.


Zhong ZA, Ethen NJ, Williams BO. 2016. Use of primary calvarial osteoblasts to evaluate the function of Wnt signaling in osteogenesis. Methods Mol Biol 1481:199–125.

Williams BO. 2016. Genetically engineered mouse models to evaluate the role of Wnt secretion in bone development and homeostasis. Am J Med Genet Semin Med Genet 172C(1):24–26.

Chin AM, Tsai YH, Finkbeiner SR, Nagy NS, Walker EM, Ethen NJ, Williams BO, Battle MA, Spence JR. 2016. A dynamic Wnt/B-catenin signaling environment leads to the Wnt-independent and Wnt-dependent proliferation of embryonic intestinal progenitor cells. Stem Cell Reports 7(5):826–839.

Burgers TA, Vivanco JF, Zahatnansky J, Moren AJ, Mason JJ, Williams BO. 2016. Mice with a heterozygous Lrp6 deletion have impaired fracture healing. Bone Res 4:16025.

Schumacher CA, Joiner DM, Less KD, Drewry MO, Williams BO. 2016. Characterization of genetically engineered mouse models carrying Col2a1-cre-induced deletions of Lrp5 and/or Lrp6. Bone Res 4:15042.

Meng X, Vander Ark A, Lee P, Hostetter G, Bhowmick NA, Matrisian LM, Williams BO, Miranti CK, Li X. 2016. Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasisOncogene 35(18):2370–2378.   

Weivoda MM, Ruan M, Hachfeld CM, Pederson L, Howe A, Davey R, Zajac J, Kobayashi Y, Williams BO, Westendorf JJ, Khosla S, Oursler MJ. 2016. Wnt signaling inhibits osteoclast differentiation by activating canonical and non-canonical cAMP/PKA pathwaysJ Bone Miner Res 31(1):65–75.

Rudnicki MA, Williams BO. 2016. Wnt signaling in bone and muscle. Bone 80:60–66.


Oursler MJ, Westendorf JJ, Weivoda MM, Ruan M, Hachfeld CM, Howe A, Davey R, Zajac J, Williams BO, Khosla S. 2015. Response to Wnt signaling pathwaysJ Bone Miner Res 30(11):2135–2136.

Chen J, Huang D, Rubera I, Futami K, Wang PF, Zickert P, Khoo SK, Dykema KJ, Zhao P, Petillo D, Cao B, Zhang Z, Si S, Schoen SR, Yang XJ, Zhou M, Xiao GQ, Wu G, Nordenskjold M, Tauc M, Williams BO, Furge KA, Teh BT. 2015. Disruption of tubular Flcn expression as a mouse model for renal tumor inductionKidney Int 88(5):1057–1069.

Zhong ZA, Zahatnansky J, Snider J, Van Wieren E, Diegel CR, Williams BO. 2015. Wntless spatially regulates bone development through β-catenin-dependent and independent mechanismsDev Dyn 244(10):1347–1355.  

Cheng SL, Ramachandran B, Behrmann A, Shao JS, Mead M, Smith C, Krchma K, Arrendondo YB, Kovacs A, Kapoor K, Brill LM, Perera R, Williams BO, Towler DA. 2015. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR–/– mice by restraining noncanonical Wnt signalsCirc Res 117(2):142–156.  

Collins CJ, Vivanco JF, Sokn SA, Williams BO, Burgers TA, Ploeg HL. 2015. Fracture healing in mice lacking Pten in osteoblasts: a micro-computed tomography image-based analysis of the mechanical properties of the femurJ Biomech 48(2):310–317.  

Peacock JD, Dykema KJ, Toriello HV, Mooney MR, Scholten DJ 2nd, Winn ME, Borgman A, Duesbery NS, Hiemenga JA, Liu C, Campbell S, Nickoloff BP, Williams BO, Steensma MR. 2015. Oculoectodermal syndrome is a mosaic RASopathy associated with KRAS alterationsAm J Med Genet A 167(7):1429–1435.  

Qin L, Yin YT, Zheng FJ, Peng LX, Yang CF, Bao YN, Liang YY, Li XJ, Xiang YQ, Sun R, Li AH, Zou RH, Pei XQ, Huang BJ, Kang TB, Liao DF, Zeng YX, Williams BO, Qian CN. 2015. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesisOncotarget 6(12):10239–10252.   

Valkenburg KC, Hostetter G, Williams BO. 2015. Concurrent hepsin overexpression and adenomatous polyposis coli deletion causes invasive prostate carcinoma in miceProstate 75(14):1579–1585.    

Zhong ZA, Peck A, Li S, VanOss J, Snider J, Droscha CJ, Chang TA, Williams BO. 2015. 99mTC-Methylene diphosphonate uptake at injury site correlates with osteoblast differentiation and mineralization during bone healing in miceBone Res 3:15013.   


Valkenburg KC, Yu X, De Marzo AM, Spiering TJ, Matusik RJ, Williams BO. 2014. Activation of Wnt/b-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia. Prostate 74(15):1506–1520.

Zhong Z, Ethen NJ, Williams BO. 2014. WNT signaling in bone development and homeostasis. Wiley Interdiscip Red Dev Biol 3(6):489–500.

Li C, Williams BO, Cao X, Wan M. 2014. LRP6 in mesenchymal stem cells is required for bone formation during bone growth and bone remodeling. Bone Res 2:14006.

Yang J, Mowry LE, Nejak-Bowen KN, Okabe H, Diegel CR, Lang RA, Williams BO, Monga SP. 2014. b-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation! Hepatology 60(3):964–976.

Scholten DJ 2nd, Timmer CM, Peacock JD, Pelle DW, Williams BO, Steensma MR. 2014. Down regulation of Wnt signaling mitigates hypoxia-induced chemoresistance in human osteosarcoma cells. PLoS One 9(10):e111431.

Cui Y, Niziolek PJ, MacDonald BT, Alenina N, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Powell DR, Bader M, Williams BO, Warman ML, Robling AG. 2014. Reply to Lrp5 regulation of bone mass and gut serotonin synthesisNat Med 20(11):1229–1230.  

Hoffmann FM, Burgers T, Mason JJ, Williams BO, Sietsema DL, Jones CB. 2014. Biomechanical evaluation of fracture fixation constructs using a variable-angle locked periprosthetic femur plate systemInjury 45(7):1035–1041.

Joiner DM, Less KD, Van Wieren EM, Hess D, Williams BO. 2014. Accelerated and increased joint damage in young mice with global inactivation of mitogen-inducible gene 6 (Mig-6) after ligament and meniscus injuryArthritis Res Ther 16(2):R81.

Kabiri Z, Greicius G, Madan B, Biechele S, Zhong Z, Zaribafzadeh H, Aliyed J, Wu Y, Bunte RM, Williams BO, Rossant J, Virshup DM. 2014. Stroma provides an intestinal stem cell niche in the absence of epithelial WntsDevelopment 141(11):2206–2215.      

Lim WH, Liu B, Cheng D, Williams BO, Mah SJ, Helms JA. 2014. Wnt signaling regulates homeostasis of the periodontal ligamentJ Periodontal Res 49(6):751–759.      

Lim WH, Liu B, Cheng D, Hunter DJ, Zhong Z, Ramos DM, Williams BO, Sharpe PT, Bardet C, Mah SJ, Helms JA. 2014. Wnt signaling regulates pulp volume and dentin thicknessJ Bone Miner Res 29(4):892–901. 

Staal B, Williams BO, Beier F, Vande Woude GF, Zhang YW. 2014. Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chrondrocyte proliferationProc Natl Acad Sci U S A 111(7):2590–2595.    

Williams BO. 2014. Insights into the mechanisms of sclerostin action in regulating bone mass accrualJ Bone Min Res 29(1):24–28.    


Burgers TA, Williams BO. 2013. Regulation of Wnt/β-catenin signaling within and from osteocytesBone 54(2):244–249. 

Burgers TA, Hoffmann MF, Collins CJ, Zahatnansky J, Alvarado MA, Morris MR, Sietsma DL, Mason JJ, Jones CB, Ploeg HL, Williams BO. 2013. Mice lacking Pten in osteoblasts have improved intramembranous and late endochondral fracture healingPLoS One 8(5):e63857. 

Hu B, Chen Y, Usmani SZ, Ye S, Qiang W, Papanikolaou X, Heuck CJ, Yaccoby S, Williams BO, Van Rhee F, Barlogie B, Epstein J, Qiang YW. 2013. Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myelomaPLoS One 8(9):e74191. 

Joiner DM, Less KD, Van Wieren EM, Hess D, Williams BO. 2013. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injuryOsteoarthritis Cartilage 21(10):1576–1585. 

Joiner DM, Ke J, Zhong Z, Xu HE, Williams BO. 2013. LRP5 and LRP6 in development and diseaseTrends Endocrin Metab 24(1):31–39.     

Ke J, Xu HE, Williams BO. 2013. Lipid modification in Wnt structure and functionCurr Opin Lipidol 24(2):129–133.     

Ke J, Harikumar KG, Jurecky C, Chen C, Gu X, Wang L, Parker N, Cheng Z, Xu W, Williams BO, Melcher K, Miller LJ, Xu HE. 2013. Structure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complexGenes Dev 27(21):2305–2319. 

Loftus JC, Dhruv H, Tuncali S, Kloss J, Yang Z, Schumacher CA, Cao B, Williams BO, Eschbacher JM, Ross JTD, Tran NL. 2013. TROY (TNFRSF19) promotes glioblastoma cell survival signaling and therapeutic resistanceMol Cancer Res 11(8): 865–874. 

Maupin KA, Droscha CJ, Williams BO. 2013. A comprehensive overview of skeletal phenotypes associated with alterations in Wnt/β-catenin signaling in humans and miceBone Res 1(1):27–71. 

Riddle RC, Diegel CR, Leslie KM, Van Koevering KK, Faugere MC, Clemens TL, Williams BO. 2013. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisitionPLoS One 8(5):e63323. 

Steensma MR, Tyler WK, Shaber AG, Goldring SR, Ross FP, Williams BO, Healey JH, Purdue PE. 2013. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategyPLoS One 8(7):e69101. 

Valkenburg KC, Steensma MR, Williams BO, Zhong Z. 2013. Skeletal metastasis: treatments, mouse models, and the Wnt signalingChin J Cancer 32(7):380–396. 


Fortin SP, Ennis MJ, Schumacher CA, Zylstra-Diegel CR, Williams BO, Ross JTD, Winkles JA, Loftus JC, Symons MH, Tran NL. 2012. Cdc42 and the guanine nucleotide exchange factors Ect2 and Trio mediate Fn14-Rac1-induced migration and invasion of glioblastoma cellsMol Cancer Res 10(7):958–968. 

Ke J, Zhang C, Harikumar KG, Zylstra-Diegel CR, Wang L, Mowry LE, Miller LJ, Williams BO, Xu HE. 2012. Modulation of β-catenin signaling by glucagon receptor activationPLoS One 7(3):e33676. 

Li Y, Ferris A, Lewis BC, Orsulic S, Williams BO, Holland EC, Hughes SH. 2012. The RCAS/TVA somatic gene transfer method in modeling human cancer. In Genetically Engineered Mice for Cancer Research, J.E. Green and T. Ried, eds. Berlin: Springer Verlag, pp. 83–112. 

Regard JB, Zhong Z, Williams BO, Yingzi Y. 2012. Wnt signaling in bone development and disease: making stronger bones with WntsCold Spring Harb Perspect Biol4(12):a007997. 

Zhong Z, Williams BO. 2012. Integration of cellular adhesion and Wnt signaling: interactions between N-cadherin and LRP5 and their role in regulating bone massJ Bone Miner Res27(9):1849–1851. 

Zhong Z, Williams BO, Steensma MR. 2012. The activation of β-catenin by Gαs contributes to the etiology of phenotypes seen in fibrous dysplasia and McCune-Albright syndromeIBMS BoneKEy 9:113. 

Zhong Z, Baker JJ, Zylstra-Diegel CR, Williams BO. 2012. Lrp5 and Lrp6 play compensatory roles in mouse intestinal developmentJ Cell Biochem 113(1):31–38. 

Zhong Z, Zylstra-Diegel CR, Schumacher CA, Baker JJ, Carpenter AC, Rao S, Yao W, Guan M, Helms JA, Lane NE, Lang RA, Williams BO. 2012. Wntless functions in mature osteoblasts to regulate bone massProc Natl Acad Sci U S A 109(33): E2197–E2204.   


Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA, Brommage R, Liu Q, Mseeh F, Powell DR, Yang QM, Zambrowicz B, Gerrits H, Gossen JA, He X, Bader M, Williams BO, Warman ML, Robling AG. 2011. Lrp5 functions in bone to regulate bone massNat Med17(6):684–691. 

Joeng KS, Schumacher C, Zylstra-Diegel CR, Long F, Williams BO. 2011. Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryoDev Biol 359(2):222–229. 

Qian CN, Williams BO. 2011. The induction of high endothelial venule remodeling by primary tumors does not correlate to the metastatic capability of tumor cellsJ Blood Lymph 1(1):e102. 

Stefater JA 3rd, Lewkowich I, Rao S, Mariggi G, Carpenter AC, Burr AR, Fan J, Ajima R, Molkentin JD, Williams BO, Wills-Karp M, Pollard JW, Yamaguchi T, Ferrara N, Gerhardt H, Lang RA. 2011. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cellsNature 474(7352):511–515. 

Valkenburg KC, Williams BO. 2011. Mouse models of prostate cancerProstate Cancer 2011: 22 pp. 

Wan M, Li J, Herbst K, Zhang J, Yu B, Wu X, Qiu T, Lei W, Lindvall C, Williams BO, Ma H, Zhang F, Cao X. 2011. LRP6 mediates cAMP generation by G protein–coupled receptors through regulating the membrane targeting of GαsSci Signal 4(164):ra15. 


Coulibaly MO, Sietsema DL, Burgers TA, Mason J, Williams BO, Jones CB. 2010. Recent advances in the use of serological bone formation markers to monitor callus development and fracture healingCrit Rev Eukaryot Gene Expr 20(2):105–127. 

Diegel CR, Cho KR, El-Naggar AK, Williams BO, Lindvall C. 2010. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinomaCancer Res 70(22):9143–9152. 

Mason JJ, Williams BO. 2010. SOST and DKK: antagonists of LRP family signaling as targets for treating bone diseaseJ Osteoporos 2010:460120.


Badders NM, Goel S, Clark RJ, Klos KS, Kim S, Bafico A, Lindvall C, Williams BO, Alexander CM. 2009. The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineagePLoS One 4(8):e6594.     

Castilho RM, Squarize CH, Chodosh LA, Williams BO, Gutkind JS. 2009. mTOR mediates Wnt-induced epidermal stem cell exhaustion and agingCell Stem Cell5(3):279–289.       

Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, Furge KA, Williams BO. 2009. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland developmentPLoS One 4(6):e5813.    

Qian CN, Furge KA, Knol J, Huang D, Chen J, Dykema KJ, Kort EJ, Massie A, Khoo SK, Vanden Beldt K, Resau JH, Anema J, Kahnoski RJ, Morreau H, Camparo P, Comperat E, Sibony M, Denoux Y, Molinie V, Vieillefond A, Eng C, Williams BO, Teh BT. 2009. Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsCancer Res 69(21):8256–8264.      

Williams BO, Insogna KL. 2009. Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in boneJ Bone Miner Res 24(2):171–178. 


Chen J, Futami K, Petillo D, Peng J, Wang P, Knol J, Li Y, Khoo SK, Huang D, Qian CN, Zhao P, Dykema K, Zhang R, Cao B, Yang XJ, Furge K, Williams BO, Teh BT. 2008. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasiaPLoS One 3(10):e3581. 

Qian Z, Chen L, Fernald AA, Williams BO, Le Beau MM. 2008. A critical role for Apc in hematopoietic stem and progenitor cell survivalJ Exp Med 205(9):2163–2175. 

Robinson DR, Zylstra CR, Williams BO. 2008. Wnt signaling and prostate cancerCurr Drug Targets 9(7):571–580. 

Shekhar MPV, Gerard B, Pauley RJ, Williams BO, Tait L. 2008. Rad6B is a positive regulator of β-catenin stabilizationCancer Res 68(6):1741–1750.    

VanKoevering KK, Williams BO. 2008. Transgenic mouse strains for conditional gene deletion during skeletal development. IBMS BoneKEy 5(5):151–170.

Wang P, Bowl MR, Bender S, Peng J, Farber L, Chen J, Ali A, Zhang Z, Alberts AS, Thakker RV, Shilatifard A, Williams BO, Teh BT. 2008. Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult miceMol Cell Biol 28(9):2930–2940.    

Wolf J, Palmby TR, Gavard J, Williams BO. 2008. Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6FEBS Letters582(2): 255–261. 

Zylstra CR, Wan C, VanKoevering KK, Sanders AK, Lindvall C, Clemens TL, Williams BO.  2008.  Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts. J Musculoskelet Neuronal Interact 8(4):291–293.


Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO. 2007. Inactivation of Apc in the mouse prostate causes prostate carcinomaCancer Res 67(6):2490–2496. 

Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO, Cho KR, Fearon ER. 2007. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivationCancer Res 67(20):9721–9730. 

Lindvall C, Bu W, Williams BO, Li Y. 2007. Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev 3(2):157–168.      

Liu X, Bruxvoort KJ, Zylstra CR, Liu J, Cichowski R, Faugere MC, Bouxsein ML, Wan C, Williams BO, Clemens TL. 2007. Lifelong accumulation of bone in mice lacking Pten in osteoblastsProc Natl Acad Sci 104(7):2259–2264.   

Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR. 2007. Mouse model of human ovarian endometroid adenocarcinoma based on somatic defects in the Wnt β-catenin and PI3K/Pten signaling pathwaysCancer Cell 11(4):321–333.  

Young JJ, Bromberg-White JL, Zylstra CR, Church JT, Boguslawski E, Resau JH, Williams BO, Duesbery NS. 2007. LRP5 and LRP6 are not required for protective antigen–mediated internalization or lethality of anthrax lethal toxinPLoS Pathog 3(3):e27.     


Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL. 2006. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growthCell 126(5):955–968.      

Lindvall C, Evans NC, Zylstra CR, Li Y, Alexander CM, Williams BO. 2006. The Wnt signaling receptor LRP5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesisJ Biol Chem 281(46):35081–35087.                       

Park KS, Jeon SH, Kim SE, Bahk YY, Holmen SL, Williams BO, Chung KC, Surh YJ, Choi KY. 2006. APC inhibits ERK pathway activation and cellular proliferation induced by RasJ Cell Sci119(5):819–827.    

Wang PF, Kong D, VanBrocklin MW, Peng J, Zhang C, Potter SJ, Gao X, Teh BT, Zhang N, Williams BO, Holmen SL. 2006. Simplified method for the construction of gene targeting vectors for conditional gene inactivation in mice. Transgenics 4:215–228.

Zhang C, Kong D, Tan MH, Pappas DL Jr, Wang PF, Chen J, Farber L, Zhang N, Koo HM, Weinreich M, Williams BO, Teh BT. 2006. Parafibromin inhibits cancer cell growth and causes G1 phase arrestBiochem Biophys Res Commun 350(1):17–24.  


Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. 2005. Prostaglandin E2 promotes colon cancer cell growth through a GS-axin-β-catenin signaling axisScience 310(5753):1504–1510. 

Holmen SL, Williams BO. 2005. Essential role for Ras signaling in glioblastoma maintenanceCancer Res 65(18) 8250–8255.   

Holmen SL, Zylstra CR, Mukherjee A, Sigler R, Faugere MC, Bouxsein M, Deng L, Clemens T, Williams BO. 2005. Essential role of ß-catenin in postnatal bone acquisitionJ Biol Chem 280(22):21162–21168.  

Holmen SL, Robertson SA, Zylstra CR, Williams BO. 2005. Wnt-independent activation of ß-catenin mediated by a Dkk-1-Frizzled 5 fusion proteinBiochem Biophys Res Commun 328(2):533–539.        

Qian CN, Knol J, Igarashi P, Lin F, Zylstra U, Teh BT, Williams BO. 2005. Cystic renal neoplasia following conditional inactivation of Apc in mouse renal tubular epitheliumJ Biol Chem280(5):3938–3945.   

Ai M, Holmen SL, Van Hul W, Williams BO, Warman ML. 2005. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signalingMol Cell Biol 25(12):4946–4955.

Robertson SA, Schoumans J, Looyenga BD, Yuhas JA, Zylstra CR, Koeman JM, Swiatek PJ, Teh BT, Williams BO. 2005. Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro. Int J Oncol 26(3):629–634.

Wang PF, Kong D, VanBrocklin MW, Peng J, Zhang C, Potter SJ, Gao X, Teh BT, Zhang N, Williams BO, Holmen SL. 2005. Simplified method for the construction of gene targeting vectors for conditional gene inactivation in mice. Transgenics 4:215–218.


Bromberg-White JL, Webb CP, Patacsil VS, Miranti CK, Williams BO, Holmen SL. 2004. Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector. J Virol 78(9):4914–4916.

Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML, Williams BO. 2004. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res 19(12): 2033–2040.

Spike BT, Dirlam A, Dibling BC, Marvin J, Williams BO, Jacks T, Macleod KF. 2004. The Rb tumor suppressor is required for stress erythropoiesis. EMBO J 23(21): 4319–4329.


Holmen SL, Salic A, Zylstra CR, Kirschner MW, Williams BO. 2002. A novel set of Wnt-Frizzled fusion proteins identifies receptor components that activate beta -catenin-dependent signaling. J Biol Chem 277(38):34727–34735.

Takahashi M, Yang XJ, Lavery TT, Furge KA, Williams BO, Tretiakova M, Montag A, Vogelzang NJ, Re GG, Garvin AJ, Soderhall S, Kagawa S, Hazel-Martin D, Nordenskjold A, Teh BT. 2002. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features. Cancer Res 62(22): 6598–6605.

Yang H, Williams BO, Hinds PW, Shih TS, Jacks T, Bronson RT, Livingston DM. 2002. Tumor suppression by a severely truncated species of retinoblastoma protein. Mol Cell Biol 22(9):3103–3110. 


Lipinski MM, Macleod KF, Williams BO, Mullaney TL, Crowley D, Jacks T. 2001. Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. EMBO J 20(13):3402–3413.


Dunn KJ, Williams BO, Li Y, Pavan WJ. 2000. Neural crest-directed gene transfer demonstrates Wnt1 role in melanocyte expansion and differentiation during mouse development. Proc Natl Acad Sci U S A 97(18):10050–10055.

Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams BO, Theodorou E, Jacks T. 2000. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev 14(23):3037–3050.

Williams BO, Barish GD, Klymkowsky MW, Varmus HE. 2000. A comparative evaluation of beta-catenin and plakoglobin signaling activity. Oncogene 19(50): 5720–5728.


Klymkowsky MW, Williams BO, Barish GD, Varmus HE, Vourgourakis YE. 1999. Membrane-anchored plakoglobins have multiple mechanisms of action in Wnt signaling. Mol Biol Cell 10(10):3151–3169.

Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE. 1999. Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 4(4):487–498.


Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T. 1998. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet 18(4):360–364. 


Herrera RE, Sah VP, Williams BO, Makela TP, Weinberg RA, Jacks T. 1996. Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol Cell Biol 16(5):2402–2407.

Lee MH, Williams BO, Mulligan G, Mukai S, Bronson RT, Dyson N, Harlow E, Jacks T. 1996. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev 10(13):1621–1632.


Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T. 1995. A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 10(2):175–180.

Tischler AS, Shih TS, Williams BO, Jacks T. 1995. Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene Nf1Endocr Pathol 6(4):323–335.

Haas AL, Baboshina O, Williams BO, Schwartz LM. 1995. Exponential increases in ubiquitin conjugate pools accompany the developmentally programmed cell death of insect skeletal muscle. J Biol Chem 270(16):9407–9412.   


Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA. 1994. Tumor spectrum analysis in p53-mutant mice. Curr Biol 4(1):1–7.

Morgenbesser SD, Williams BO, Jacks T, DePinho RA. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371(6492):72–74.

Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR. 1994.  p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci U S A 91(12):5320–5324.

Williams BO, Morgenbesser SD, DePinho RA, Jacks T. 1994. Tumorigenic and developmental effects of combined germ-line mutations in Rb and p53. Cold Spring Harb Symp Quant Biol 59: 449–457.

Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. 1994. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7(4):480–484.

Williams BO, Schmitt EM, Remington L, Bronson RT, Albert DM, Weinberg RM, Jacks T. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequencesEMBO J 13(18):4251–4259.


Chen J, Gorman JR, Stewart V, Williams BO, Jacks T, Alt FW. 1993. Generation of normal lymphocyte populations by Rb-deficient embryonic stem cells. Curr Biol 3(7):405–413.

Zettergren LD, Cutlan R, Williams BO. 1991. Embryonic dorsal region compartments in B lymphopoiesis: Rana pipiens, Gallus gallus, and Mus musculus. Dev Comp Immunol 15:105S.